Stay updated on Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial page
- Check6 days agoChange DetectedThe revision label was updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded numerous new trial site locations across multiple countries and removed several existing sites. This changes the geographic enrollment options available to potential participants.SummaryDifference5%

- Check34 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice and the previous Revision: v3.4.1 banner.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the revision to v3.4.1 (removing v3.4.0).SummaryDifference0.2%

- Check48 days agoChange DetectedShow glossary is now available, and the label for QC updates has been updated to 'Last Update Submitted that Met QC Criteria'. The page now includes a 'No FEAR Act Data' notice and shows the site revision as 'Revision: v3.4.0' (replacing 'v3.3.4').SummaryDifference0.1%

- Check84 days agoChange DetectedLocations section reorganized under a single Locations heading, adding a comprehensive list of study sites across multiple regions. Individual location headings were removed and replaced with the consolidated locations list.SummaryDifference2%

Stay in the know with updates to Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial page.